Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of chemotherapy with rituximab in patients with chronic lymphocytic leukemia or lymphocytic lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Lymphocytic Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Hoag Memorial Hospital Presbyterian | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED